trial · primary record
CV09070101 mRNA vaccine (CVHNLC) 50 µg
Squamous NSCLC
| Phase | Phase 1 |
|---|---|
| Status | TERMINATED |
| Sponsor | Unknown |
| Enrolment | Not stated |
| Primary completion | 2029-12-31 |
| Primary endpoint | Incidence of treatment-related adverse events (TRAEs) |
| Registry ID | NCT07073183 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:43:28.797Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07073183
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.